Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes

Clinical Research in Cardiology

Volumn 102, Issue 10, 2013, Pages 755-763

  Afzali, Dariush ^a   Erren, Michael ^a   Pavenstädt, Hermann Joseph ^a   Vollert, Jörn Ole ^b   Hertel, Sabine ^b   Waltenberger, Johannes ^a   Reinecke, Holger ^a   Lebiedz, Pia ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Acute coronary syndrome; Copeptin; Prognosis; Rule out; Troponin I

Indexed keywords

COPEPTIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GLYCOPEPTIDES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TIME FACTORS; TROPONIN I;

EID: 84884818044     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0583-0     Document Type: Article

References (24)

1. Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 32:2999-3054
2. Melanson SE, Morrow DA, Jarolim P (2007) Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 128:282-286
3. Mueller M, Celik S, Biener M et al (2012) Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol 101:837-845
4. Tousoulis D, Kampoli AM, Stefanadi E et al (2008) New biochemical markers in acute coronary syndromes. Curr Med Chem 15:1288-1296
5. McCann CJ, Glover BM, Menown IB et al (2008) Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 29(23):2843-2850
6. Kurz K, Giannitsis E, Becker M et al (2011) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cadiol 100:209-215. doi: 10.1007/s00392-010-0230-y
7. Reichlin T, Hochholzer W, Stelzig C et al (2009) Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 54:60-68. doi: 10.1016/j.jacc.2009.01.076
8. Keller T, Tzikas S, Zeller T et al (2010) Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55:2096-2106. doi: 10.1016/j.jacc.2010.01.029
9. Gu YL, Voors AA, Zijlstra F et al (2011) Comparison of temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol 100:1069-1076. doi: 10.1007/s00392-011-0343-y
10. Stoiser B, Mortl D, Hulsmann N et al (2006) Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 36(11):771-778
11. Khan SQ, Dhillon OS, O'Brien RJ et al (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: leicester acute myocardial infarction peptide (LAMP) study. Circulation 115:2103-2110. doi: 10.1161/CIRCULATIONAHA.106685503
12. Von Haehling S, Papassotiriou J, Morgenthaler NG et al (2012) Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. Int J Cardiol. doi: 10.1016/j.ijcard.2011.12.105
13. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM (2008) Use of the centaur TnI-ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 54:723-728
14. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ (2004) Regulatory mechanisms of corticotrophin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 16:348-355. doi: 10.1111/j.0953-8194.2004.01172. x
15. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119. doi: 10.1373/clinchem.2005.060038
16. Katan M, Morgenthaler N, Widmer I et al (2008) Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 29:341-346
17. Staub D, Morgenthaler NG, Buser C et al (2009) Use of copeptin in the detection of myocardial ischemia. Clin Chim Acta 399:69-73. doi: 10.1016/j.cca.2008.09016
18. Giannitsis E, Kehayova T, Vafaie M, Katus HA (2011) combined testing of high-sensitivity troponin t and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem 57(10):1452-1455
19. Narayan H, Dhillon OS, Quinn PA et al (2011) C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: leicester acute myocardial infarction peptide II (LAMP II) study. Clin Sci (Lond) 121(2):79-89
20. Voors AA, von Haehling S, Anker SD et al (2009) C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 30(10):1187-1194. doi: 10.1093/eurheartj/ehp098
21. Urwyler SA, Schuetz P, Fluri F et al (2010) Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 41:1564-1567
22. Potocki M, Reichlin T, Thalman S et al (2012) Diagnostic and prognostic impact of copeptin and high-senstivity cardiac troponin T in patients with pre-existing coronary arter disease and suspected acute myocardial infarction. Heart 98:558-565
23. Celik S, Giannitsis E, Wollert KC et al (2011) Cardiac troponin T cencentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol 100:1077-1085. doi: 10.1007/s00392-011-0344-x
24. Lotze U, Lemm H, Heyer A, Muller K (2011) Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital. Vasc Health Risk Manag. 7:509-515